Table 3.
Aggregate utilities of analgesic treatment for cancer pain "by race" over-time
| |
At baseline (N = 241) |
At 3-months (N = 201) |
||||
|---|---|---|---|---|---|---|
| Attributes & levels† | Whites (N = 139) | African-Americans (N = 102) | p-values | Whites (N = 114) | African-Americans (N = 87) | p-values |
|
% Pain relief with analgesics |
36.71
‡
|
26.83
‡
|
<0.001 |
35.65
‡
|
27.45
‡
|
.006 |
| < 50% |
−102.5 |
−73.8 |
.000 |
−101.7 |
−78.8 |
.006 |
| 60-70% |
−15.7 |
−9.12 |
.002 |
−15.2 |
−11.9 |
.337 |
| 80-90% |
37.1 |
22.6 |
.000 |
40.4 |
32.3 |
.062 |
| 100% |
81.1 |
60.3 |
.000 |
76.5 |
58.5 |
.007 |
|
Type of analgesic side-effects |
19.29
‡
|
28.72
‡
|
<0.001 |
16.96
‡
|
23.30
‡
|
.009 |
| Confusion |
−32.1 |
−45.5 |
.081 |
−11.7 |
−38.8 |
.000 |
| Drowsiness/dizziness |
21.0 |
27.6 |
.145 |
12.8 |
11.1 |
.717 |
| Heartburn/sour stomach |
13.3 |
14.4 |
.865 |
7.8 |
11.0 |
.518 |
| Constipation |
18.9 |
14.2 |
.448 |
13.5 |
26.5 |
.047 |
| Nausea/vomiting |
−21.1 |
−10.7 |
.056 |
−22.4 |
−9.8 |
.048 |
|
Severity of side-effects |
18.55
‡
|
16.81
‡
|
.225 |
19.03
‡
|
14.71
‡
|
.027 |
| Mild |
33.0 |
31.8 |
.636 |
38.2 |
28.7 |
.022 |
| Moderate |
26.7 |
20.6 |
.010 |
18.7 |
16.1 |
.212 |
| Severe |
−59.7 |
−52.3 |
.112 |
−56.9 |
−44.8 |
.034 |
|
Type of analgesic |
13.52‡ |
16.66‡ |
.176 |
14.83‡ |
17.19‡ |
.413 |
| Oxycontin or morphine-like pain medicine |
19.9 |
19.0 |
.904 |
23.4 |
13.8 |
.272 |
| Motrin or aleve-like pain medicine |
−19.9 |
−19.0 |
.904 |
−23.4 |
−13.8 |
.272 |
|
Out of pocket cost |
11.93‡ |
10.98‡ |
.355 |
13.51‡ |
17.33‡ |
.017 |
| $10-$20 |
25.0 |
23.8 |
.608 |
24.7 |
33.9 |
.003 |
| $30-$40 |
22.0 |
19.1 |
.122 |
16.1 |
21.2 |
.019 |
| $50-$60 |
-.11 |
-.23 |
.889 |
7.9 |
4.6 |
.023 |
| $70-$90 |
−12.3 |
−11.5 |
.598 |
−5.9 |
−7.1 |
.466 |
| $100 or more | −34.6 | −31.1 | .232 | −42.8 | −52.7 | .037 |
†Aggregate utilities associated with each level of the attribute; smaller or more negative preference weight indicates less preference for that level of an attribute.
‡Relative importance scores sum to 100 across all attributes. P-values are based on 2-tailed two sample t-test.